Welcome to the

Hypertrophic Cardiomyopathy Program

Our experts have more than 25 years of experience managing this heart condition.

At NYU Langone’s Hypertrophic Cardiomyopathy Program, our cardiologists and heart surgeons have more than 25 years of experience treating people with hypertrophic cardiomyopathy, also known as HCM. NYU Langone is one of only a handful of institutions in the United States to offer comprehensive management of hypertrophic cardiomyopathy.

Hypertrophic cardiomyopathy is a heart condition caused by a thickening of the heart muscle. Symptoms include shortness of breath, chest pressure, blackouts, and lightheadedness. In some people, the heart becomes stiff and cannot fill properly. In others, the flow of blood out of the heart is obstructed.

Because of these abnormalities, the heart cannot pump enough blood to the rest of the body. This is especially true during exercise. Hypertrophic cardiomyopathy can be associated with irregular heart rhythms that in some people can be dangerous.

Our team includes a cardiologist who discusses diagnosis and treatment options with you in detail, a surgeon who is an expert and innovator in the repair of hypertrophic cardiomyopathy, specialists from the Heart Rhythm Center who diagnose heart rhythm irregularities, and experts in the insertion and management of devices that correct heart rhythm.

We also offer genetic screening, DNA analysis, and counseling for family members of people with hypertrophic cardiomyopathy. Such information can reveal which members of your family might have inherited a predisposition to the condition.

Learn more about how we diagnose and treat hypertrophic cardiomyopathy.

Our Team

Our cardiologist and heart surgeon are innovators in the treatment of patients with hypertrophic cardiomyopathy.

View All Doctors

Our Leadership

  • Mark V. Sherrid, MD
    Program Director | Cardiology

    Dr. Sherrid is a nationally recognized cardiologist with more than 25 years of experience diagnosing, consulting with, and managing treatment for patients with hypertrophic cardiomyopathy. He’s also a researcher who has published more than 35 journal articles about the diagnosis and treatment of hypertrophic cardiomyopathy. Dr. Sherrid has lectured at conferences throughout the United States and Europe.

    View Full Profile
  • Daniel G. Swistel, MD
    Program Surgical Director | Cardiac Surgery

    Dr. Swistel is one of the few surgeons in the United States with extensive experience performing myectomy, which is surgery for hypertrophic cardiomyopathy. When necessary to relieve an obstruction, Dr. Swistel simultaneously repairs the mitral valve. He has published numerous journal articles about unique innovations in hypertrophic cardiomyopathy surgery that have made procedures safer and more successful.

    View Full Profile

Plan Your Visit

Our Location

Hypertrophic Cardiomyopathy Program

530 First Avenue
Skirball Suite 9N, Silverstein Elevators
New York, NY 10016

Related News